Severe Asthma & Lung Function

Trial Objective

Researchers are trying to better understand an injectable medication that was recently approved for poorly controlled severe asthma, including time of effect onset, change in lung function while on treatment, and safety. 

Severe Asthma & Lung Function

Enrollment

This trial is active and currently recruiting.

How to Participate

For more information, call 303.398.1708 or complete the form below.

Who Can Participate

People with severe asthma that is not well controlled.


Estimated Time Commitment

11 visits over up to 22 weeks

Trial Location

National Jewish Main Campus, Denver, CO

Compensation

Provided

Trial Sponsors

AstraZeneca AB

Age

18-75


Gender

Any Gender

Principal Investigators


Request More Information

*
*
*
*